Crainio Secures Seed Funding to Advance Product Toward Clinical Accuracy and Design Freeze

August 2025

We’re thrilled to announce that Crainio has successfully closed its seed funding round, backed by a group of angel investors and the NLC Health Impact Fund.

This investment marks a major milestone in our mission to bring Crainio’s innovative technology to clinical-grade reliability — meeting standard-of-care levels of accuracy for use in real-world healthcare settings. The funding will also support our progress toward hardware design freeze, ensuring our solution is ready for scalable manufacturing and regulatory validation.

With this support, Crainio is poised to accelerate development, strengthen data validation efforts, and deepen collaborations with clinical partners to make early, accessible, and precise neurological diagnostics a reality.

Stay tuned — exciting milestones are ahead as we continue shaping the future of brain health technology.